Anuncia Medical has developed innovative technologies aimed at addressing the challenges associated with hydrocephalus treatment, particularly focusing on shunt occlusions. The ReFlow™ System Mini and the ReFlow™ Mini Flusher represent a significant advancement in noninvasive techniques for managing cerebrospinal fluid (CSF) flow within shunt systems. These devices are designed to be implanted under the scalp and work by allowing a controlled flush of fluid to be sent toward the ventricular catheter, which can help clear blockages and restore normal CSF flow. This approach not only aims to reduce the need for surgical interventions but also empowers patients and clinicians to manage shunt functionality more effectively.

The ReFlow™ technology was developed through collaboration with hydrocephalus experts and is built to integrate seamlessly with existing shunt systems. The ReFlow™ Mini Flusher can be used with various ventricular catheters, enhancing its versatility in clinical settings. By addressing one of the most common issues faced by patients with hydrocephalus—ventricular catheter occlusions—Anuncia Medical's solutions aim to improve patient outcomes and quality of life, ultimately reducing the frequency of emergency shunt revision surgeries. This innovative approach positions Anuncia Medical as a leader in the neurotherapeutic device space, focusing on the unmet needs in CSF management and neurocritical care.

United States

Anuncia Medical is a neurotherapeutic device company currently solving the large unmet need in cerebrospinal fluid (CSF) management and neurocritical care.

Anuncia Medical

Company Details